CCN3 is a therapeutic target relating enhanced stemness and coagulation in hepatocellular carcinoma

The general prognosis of patients with hepatocellular carcinoma (HCC) remains extremely dismal, due to the high frequency of metastasis. Since 2003, our research group has explored the gene expression profiles of metastasized HCC tissue samples and identified a significant upregulation of CCN3. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qingan, Xue, Tongchun, Zhang, Qiangbo, Cheng, Wei, Zhang, Chun, Ma, Jingwei, Bu, Yang, Yu, Songning, Liu, Qingguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653869/
https://www.ncbi.nlm.nih.gov/pubmed/29061995
http://dx.doi.org/10.1038/s41598-017-14087-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653869/
https://www.ncbi.nlm.nih.gov/pubmed/29061995
http://dx.doi.org/10.1038/s41598-017-14087-4

Ejemplares similares